Use of a super active luteinizing hormone releasing hormone (LHRH) agonist in the treatment of menorrhagia

Authors:

Abstract
Summary. A luteinizing hormone releasing hormone agonist, d‐Ser(But)6des Gly10‐LHRH ethylamide, was administered intranasally to four women with unexplained ovulatory menorrhagia. Dramatic reductions in excessive menstrual blood losses were induced without significant side‐effects, although the pattern of loss returned to pretreatment levels within 2 months of ceasing therapy.

This publication has 7 references indexed in Scilit: